Don't let meatheads who post drivel like 'guess you were wrong then' put you off contributing, CardioKing. We need people without rose-coloured glasses here.
I don't think it's a matter of losing faith. Any hint of efficacy and this will rocket. But, as you indicate, there is no timeline for efficacy studies. I suspect we won't see any until 2022. And investors these days are very focused on the short term. They'll be back upon the announcement of phase 2 trials.
Don't let meatheads who post drivel like 'guess you were wrong...
Add NSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.002(3.77%) |
Mkt cap ! $7.953M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.5¢ | 5.3¢ | $1.035K | 19.47K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 15688 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 211999 | 2 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.3¢ |
Change
0.002 ( 3.92 %) |
||||
| Open | High | Low | Volume | ||
| 5.4¢ | 5.4¢ | 5.3¢ | 2796 | ||
| Last updated 13.17pm 03/05/2024 ? | |||||
| NSB (ASX) Chart |